维普中文期刊产品整合服务
133篇 您的检索式:作者名="Kelly MG"
    题名 作者 年代 出处 被引量
1Improved survival in surgical stage Ⅰ patients with uterine papillary serious carcinoma (UPSC) treated with adjuvant platinum - based chemotherapy显示文摘Kelly MG Oinalley DM Hui P 2005Gynecol Oncol2005,98,:1
2The biological effects and chemical composition of podophyllin 显示文摘Kelly MG Hartwell JL 1954J Natl Cancer Inst1954,14,:1
3Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy显示文摘Kelly MG O'Malley DM Hui P 2005Gynecol Onco12005,98,:1
4Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy显示文摘Kelly MG O'malley DM Hui P 2005Gynecol Oncol2005,98,3:1
5Carcinosarcoma of the ovary 显示文摘Silasi DA Illuzzi JL Kelly MG 2008Int J Gynecol Cancer2008,18,1:1
6Neoadjuvant chemothcrapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease显示文摘HouJY Kelly MG Yu H 2007Gynecol Oncol2007,105,1:1
7Auditory brainstem response, middle latency response, and late cortical evoked potentials in children with learning disabilities显示文摘Purdy SC Kelly AS Davies MG 2002J Am Acad Audiol2002,13,7:1
8TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer显示文摘Kelly MG Alvero AB Chen R 2006Cancer Res2006,66,7:1
9Population study of causes,treatment,and outcome of inferlitity显示文摘Hull MG Glazener CM Kelly NJ 1985Br Med J1985,291,6510:1
10Large cell neuroendocrine carcinoma of the cervix:prognostic factors and survival advantage with platinum chemotherapy显示文摘Embry JR Kelly MG Post MD 2011Gynecol Oncol2011,120,3:1
11Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease 显示文摘Hou JY Kelly MG Yu H 2007Gyneeol Oncol2007,105,1:1
12TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer显示文摘 Alvero AB Chen R 2006Cancer Res2006,66,7:1
13Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy显示文摘Kelly MG O'Malley DM Hui P 2005Gynecol Oncol2005,98,3:1
14Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease 显示文摘Hou JY Kelly MG Yu H 2007Gynecol Oncol2007,105,1:1
15TLR-4 signaling pro- motes tumor growth and paclitaxel chemoresistance in o- varian cance显示文摘Kelly MG Alvero AB Chen R 2006Cancer Res2006,66,7:1
16Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease显示文摘Hou JY Kelly MG Yu H 0,,:1
17Improved survival in surgical stage I patients with uterine papillary serous carcinoma(UPSC)treated with adjuvant platinum-based chemotherapy显示文摘Kelly MG O'malley DM Hui P 2005Gynecol Oncol2005,98,3:1
18TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer显示文摘 Alvero AB Chen R 2006Cancer Res2006,66,7:1
19Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation显示文摘Kelly MG O'Malley D McAlpine HJ 2004Gynecol Oncol2004,95,:1
20Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy 显示文摘Embry JR Kelly MG Post MD 2011Gynecol Oncol2011,120,3:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费